UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1964) 1964
Book Chapter (20) 20
Newsletter (12) 12
Magazine Article (5) 5
Book / eBook (2) 2
Newspaper Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1440) 1440
life sciences & biomedicine (1344) 1344
humans (1158) 1158
cachexia (1058) 1058
animals (927) 927
male (862) 862
cachexia - etiology (659) 659
female (635) 635
mice (498) 498
cancer (490) 490
cachexia - pathology (425) 425
oncology (407) 407
middle aged (356) 356
cachexia - metabolism (352) 352
muscle, skeletal - pathology (337) 337
aged (324) 324
muscle, skeletal - metabolism (256) 256
neoplasms - complications (229) 229
adult (224) 224
musculoskeletal system (218) 218
cancer cachexia (217) 217
rats (214) 214
body weight (212) 212
cell biology (205) 205
muscles (197) 197
disease models, animal (194) 194
research (189) 189
cachexia - physiopathology (187) 187
cachexia - drug therapy (185) 185
inflammation (184) 184
skeletal muscle (182) 182
proteins (181) 181
weight loss (176) 176
neoplasms - pathology (172) 172
cytokines (170) 170
cachexia - complications (165) 165
health aspects (155) 155
physiological aspects (152) 152
biochemistry & molecular biology (148) 148
metabolism (148) 148
analysis (145) 145
rodents (145) 145
atrophy (143) 143
physiology (142) 142
sarcopenia (142) 142
care and treatment (141) 141
tumors (133) 133
prognosis (132) 132
nutrition & dietetics (130) 130
mice, inbred c57bl (129) 129
cell line, tumor (128) 128
pathology (125) 125
research article (121) 121
quality of life (120) 120
signal transduction (120) 120
abridged index medicus (115) 115
body composition (115) 115
chemotherapy (115) 115
gene expression (115) 115
body mass index (113) 113
cachexia - genetics (111) 111
anorexia (109) 109
general & internal medicine (109) 109
aged, 80 and over (108) 108
cachexia - prevention & control (108) 108
medicine (107) 107
geriatrics & gerontology (106) 106
mice, inbred balb c (106) 106
muscle, skeletal - drug effects (105) 105
muscular atrophy - pathology (105) 105
patients (105) 105
medicine, general & internal (104) 104
neoplasms - metabolism (103) 103
cancer therapies (102) 102
endocrinology & metabolism (102) 102
neoplasm transplantation (102) 102
muscle wasting (99) 99
science & technology - other topics (97) 97
multidisciplinary sciences (96) 96
medicine & public health (93) 93
muscular atrophy - metabolism (93) 93
rats, wistar (93) 93
nutrition (92) 92
apoptosis (91) 91
surgery (90) 90
risk factors (89) 89
muscular atrophy - etiology (86) 86
studies (85) 85
cachexia - therapy (84) 84
mortality (83) 83
immunology (82) 82
original (82) 82
muscle proteins - metabolism (79) 79
time factors (79) 79
heart failure (78) 78
neoplasm staging (78) 78
body weight - drug effects (76) 76
pancreatic cancer (75) 75
development and progression (74) 74
exercise (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1914) 1914
German (29) 29
French (26) 26
Japanese (18) 18
Russian (18) 18
Portuguese (9) 9
Spanish (6) 6
Polish (5) 5
Hungarian (3) 3
Italian (3) 3
Bulgarian (1) 1
Chinese (1) 1
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, ISSN 0363-6119, 09/2011, Volume 301, Issue 3, pp. 716 - 726
Cancer cachexia describes the progressive skeletal muscle wasting and weakness in many cancer patients and accounts for >20% of cancer-related deaths. We... 
Atrophy | Muscle weakness | Muscle function | Muscle wasting | Life Sciences & Biomedicine | Physiology | Science & Technology | Phosphorylation | Cachexia - drug therapy | Apoptosis - drug effects | Male | Muscle, Skeletal - metabolism | Smad3 Protein - metabolism | Carcinoma, Lewis Lung - complications | Muscular Atrophy - physiopathology | Time Factors | Muscle, Skeletal - drug effects | Cachexia - etiology | Muscle Weakness - pathology | Myostatin - metabolism | Cachexia - metabolism | Muscular Atrophy - etiology | Muscle Weakness - etiology | Muscular Atrophy - metabolism | Oxidation-Reduction | Mice, Inbred C57BL | Muscular Atrophy - pathology | Muscular Atrophy - drug therapy | Myostatin - antagonists & inhibitors | Antibodies - pharmacology | Animals | Analysis of Variance | Cachexia - pathology | Muscle Weakness - drug therapy | Muscle, Skeletal - physiopathology | Muscle Weakness - metabolism | Carcinoma, Lewis Lung - pathology | Succinate Dehydrogenase - metabolism | Cell Proliferation - drug effects | Mice | Muscle Strength - drug effects | Muscle Weakness - physiopathology | Muscle, Skeletal - pathology | Energy Metabolism - drug effects | Myostatin - immunology | Cachexia - physiopathology | Viral antibodies | Physiological aspects | Antibodies | Myostatin | Development and progression | Research | Health aspects | Atrophy, Muscular | Tumors | Muscular system | Rodents | Cancer | Apoptosis | Index Medicus
Journal Article
Journal of cellular physiology, ISSN 1097-4652, 11/2018, Volume 234, Issue 7, pp. 11315 - 11329
Impaired muscle strength and mass (sarcopenia) are common in patients with respiratory cachexia, namely chronic obstructive pulmonary disease (COPD) and in... 
lung cancer | chronic and subacute respiratory sarcopenic conditions | unfolded protein response | endoplasmic reticulum stress | lower limb muscles | COPD | Physiology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Prospective Studies | Cross-Sectional Studies | Endoribonucleases - metabolism | Gene Expression - genetics | eIF-2 Kinase - metabolism | Humans | Middle Aged | Muscular Atrophy - pathology | Oxidative Stress - physiology | Male | Autophagy - physiology | Endoplasmic Reticulum - pathology | Activating Transcription Factor 6 - metabolism | Cachexia - pathology | Sarcopenia - pathology | Female | Aged | Apoptosis - physiology | Quadriceps Muscle - pathology | Unfolded Protein Response - physiology | Protein-Serine-Threonine Kinases - metabolism | Endoplasmic Reticulum Stress - physiology | Muscle Strength - physiology | Proteins | Inositol | Lung diseases, Obstructive | Proteolysis | Protein kinases | Lung cancer | Oxidative stress | Reverse transcription | Immunoblotting | Kinases | Autophagy | Atrophy | Sarcopenia | Protein folding | Chronic obstructive pulmonary disease | Muscular strength | Chronic illnesses | Lung diseases | Markers | Muscles | Histology | Cachexia | Patients | Polymerase chain reaction | Protein kinase | Respiratory diseases | Obstructive lung disease | Quadriceps muscle | Endoplasmic reticulum | Phagocytosis | Cancer | Apoptosis | Index Medicus | Pulmons | Chronic and subacute respiratory sarcopenic conditions | Lower limb muscles | Malalties obstructives | Endoplasmic reticulum stress | Unfolded protein response
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 06/2011, Volume 333, Issue 6039, pp. 233 - 238
Journal Article
Journal Article
Journal Article
American journal of physiology: endocrinology and metabolism, ISSN 1522-1555, 08/2012, Volume 303, Issue 3, pp. E410 - E421
Cachexia, the metabolic dysregulation leading to sustained loss of muscle and adipose tissue, is a devastating complication of cancer and other chronic... 
Signal transducer and activator of transcription | Incb018424 | Electroporation | Inhibitory peptide | T cell protein tyrosine phosphatase/ protein tyrosine phosphatase | Janus-activated kinase | Interleukin-6 | Atrophy | Burn | Suppressors of cytokine signaling 3 | Lipopolysaccharide | Sepsis | Nonreceptor type 2 | Endocrinology & Metabolism | Physiology | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | Wasting Syndrome - prevention & control | Wasting Syndrome - metabolism | Cricetulus | Male | Muscle, Skeletal - metabolism | Janus Kinases - metabolism | Neoplasms - complications | Neoplasms - genetics | Muscle, Skeletal - drug effects | Cachexia - etiology | Interleukin-6 - physiology | Female | Interleukin-6 - metabolism | STAT3 Transcription Factor - genetics | STAT3 Transcription Factor - metabolism | CHO Cells | Disease Models, Animal | Pyrazoles - pharmacology | Cricetinae | Cachexia - genetics | Interleukin-6 - genetics | Janus Kinases - genetics | Mice, Inbred C57BL | RNA, Small Interfering - pharmacology | Cells, Cultured | Mutant Proteins - genetics | Mice, Transgenic | Signal Transduction - genetics | Wasting Syndrome - genetics | Cachexia - prevention & control | Mutant Proteins - administration & dosage | Neoplasms - drug therapy | Janus Kinases - antagonists & inhibitors | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Mice, Nude | Cachexia - pathology | Mice | Protein Kinase Inhibitors - pharmacology | Muscle, Skeletal - pathology | RNA, Small Interfering - administration & dosage | STAT3 Transcription Factor - antagonists & inhibitors | Wasting Syndrome - pathology | Transcription factors | Control | Analysis | Muscles | Genetic aspects | Wasting syndrome | Musculoskeletal system | Inhibitor drugs | Cytokines | Ligands | Metabolic disorders | Cancer | Index Medicus | incb018424 | protein tyrosine phosphatase, nonreceptor type 2 | burn | suppressors of cytokine signaling 3 | atrophy | signal transducer and activator of transcription 3 inhibitory peptide | electroporation | T cell protein tyrosine phosphatase | lipopolysaccharide | interleukin-6 | sepsis
Journal Article
Journal Article